CytomX Therapeutics, Inc. SEC filings CTMX
CytomX Therapeutics, Inc. has 800 filings in SEC EDGAR's recent list, going back to Sep 28, 2010. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | Mar 18, 2026 | — |
| 424B5 | Prospectus supplement | Mar 16, 2026 | — |
| S-3ASR | Automatic shelf registration | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | May 12, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | Mar 11, 2024 | — |
| 424B3 | Prospectus | Aug 28, 2023 | — |
| S-3 | Shelf registration | Aug 16, 2023 | — |
| S-8 | Employee stock plan registration | Mar 27, 2023 | — |
| 424B5 | Prospectus supplement | Mar 4, 2022 | — |
| S-8 | Employee stock plan registration | Mar 4, 2022 | — |
| S-3/A | Filing | Aug 17, 2021 | — |
| S-3 | Shelf registration | Aug 5, 2021 | — |
| S-8 | Employee stock plan registration | May 6, 2021 | — |
| S-8 | Employee stock plan registration | Feb 24, 2021 | — |
| 424B5 | Prospectus supplement | Jan 21, 2021 | — |
| 424B5 | Prospectus supplement | Jan 19, 2021 | — |
| 424B5 | Prospectus supplement | Feb 27, 2020 | — |
| S-8 | Employee stock plan registration | Feb 27, 2020 | — |
| S-8 | Employee stock plan registration | Feb 27, 2019 | — |
| S-3/A | Filing | Feb 6, 2019 | — |
| S-3 | Shelf registration | Nov 6, 2018 | — |
| 424B5 | Prospectus supplement | Jul 13, 2018 | — |
| 424B5 | Prospectus supplement | Jul 10, 2018 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| S-3 | Shelf registration | Mar 9, 2017 | — |
| S-8 | Employee stock plan registration | Jan 27, 2017 | — |
| S-3/A | Amendment no. 1 to form s-3 | Nov 23, 2016 | — |
| S-3 | Shelf registration | Nov 3, 2016 | — |
| S-8 | Employee stock plan registration | Mar 7, 2016 | — |
| S-8 | Employee stock plan registration | Oct 30, 2015 | — |
| 424B4 | Prospectus | Oct 8, 2015 | — |
| S-1/A | Amended registration statement | Oct 6, 2015 | — |
| S-1/A | Amended registration statement | Oct 2, 2015 | — |
| S-1/A | Amended registration statement | Sep 28, 2015 | — |
| S-1/A | Amended registration statement | Sep 18, 2015 | — |
| S-1/A | Amended registration statement | Sep 11, 2015 | — |
| S-1 | Registration statement | Aug 28, 2015 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTMX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1501989
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.